Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsInterest & Investment IncomeNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Non Operating Investment Income (2020 - 2025)

Historic Non Operating Investment Income for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to $21.6 million.

  • Roivant Sciences' Non Operating Investment Income rose 20130.43% to $21.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $109.7 million, marking a year-over-year increase of 24460.72%. This contributed to the annual value of $55.2 million for FY2025, which is 21503.55% up from last year.
  • As of Q4 2025, Roivant Sciences' Non Operating Investment Income stood at $21.6 million, which was up 20130.43% from $128.5 million recorded in Q3 2025.
  • Roivant Sciences' 5-year Non Operating Investment Income high stood at $443.8 million for Q3 2021, and its period low was -$54.7 million during Q3 2022.
  • For the 5-year period, Roivant Sciences' Non Operating Investment Income averaged around $30.2 million, with its median value being -$8.6 million (2021).
  • Per our database at Business Quant, Roivant Sciences' Non Operating Investment Income soared by 42641.73% in 2021 and then tumbled by 22560.75% in 2025.
  • Roivant Sciences' Non Operating Investment Income (Quarter) stood at -$38.0 million in 2021, then surged by 168.22% to $25.9 million in 2022, then crashed by 140.34% to -$10.5 million in 2023, then tumbled by 103.63% to -$21.3 million in 2024, then skyrocketed by 201.3% to $21.6 million in 2025.
  • Its Non Operating Investment Income stands at $21.6 million for Q4 2025, versus $128.5 million for Q3 2025 and -$19.1 million for Q2 2025.